Ausdal Financial Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,967
| Closed | -$234K | – | 533 |
|
|
2024
Q2 | $234K | Buy |
+1,967
| New | +$234K | 0.02% | 445 |
|
|
2023
Q3 | – | Sell |
-1,945
| Closed | -$236K | – | 450 |
|
|
2023
Q2 | $236K | Sell |
1,945
-330
| -15% | -$40.1K | 0.03% | 362 |
|
|
2023
Q1 | $349K | Buy |
2,275
+234
| +11% | +$35.9K | 0.05% | 308 |
|
|
2022
Q4 | $367K | Buy |
+2,041
| New | +$367K | 0.05% | 294 |
|
|
2022
Q3 | – | Sell |
-1,675
| Closed | -$239K | – | 464 |
|
|
2022
Q2 | $239K | Buy |
1,675
+473
| +39% | +$67.5K | 0.04% | 388 |
|
|
2022
Q1 | $207K | Buy |
1,202
+142
| +13% | +$24.5K | 0.03% | 445 |
|
|
2021
Q4 | $269K | Buy |
1,060
+309
| +41% | +$78.4K | 0.04% | 388 |
|
|
2021
Q3 | $289K | Buy |
+751
| New | +$289K | 0.04% | 367 |
|
|
2021
Q2 | – | Sell |
-1,564
| Closed | -$205K | – | 478 |
|
|
2021
Q1 | $205K | Sell |
1,564
-1,994
| -56% | -$261K | 0.03% | 413 |
|
|
2020
Q4 | $278K | Buy |
3,558
+244
| +7% | +$19.1K | 0.05% | 325 |
|
|
2020
Q3 | $234K | Buy |
+3,314
| New | +$234K | 0.06% | 303 |
|